Beat The Denominator

A specific MicroStrategy perpetual preferred stock offers a compelling dual investment opportunity with a current yield of 8.2%. The primary thesis is a bet on falling interest rates, which could cause the security's price to appreciate from $97 towards a target of $150-$200. This investment also provides long-term upside, as it becomes convertible into MSTR common stock if MSTR's price surpasses $1,000 per share. Unlike traditional bonds, this security is heavily collateralized by MicroStrategy's Bitcoin holdings, providing significant downside protection. This structure allows investors to capture potential gains from both interest rate cuts and MSTR's growth while receiving a steady income.

With the Federal Reserve expected to begin a rate cut cycle, consider growth stocks that benefit from lower borrowing costs. SoFi (SOFI) is a prime beneficiary, poised for significant growth from an anticipated wave of loan refinancing. For real estate exposure, The Real Brokerage (REAX) is presented as an undervalued, high-growth company that should thrive as lower mortgage rates spur more transactions. To gain leveraged exposure to the bullish outlook on Bitcoin (BTC), consider MicroStrategy (MSTR) as a key holding. Finally, residential solar firm Enphase (ENPH) is a strong turnaround candidate, as lower interest rates will make financing solar installations much more affordable for consumers.

Consider buying MicroStrategy (MSTR) on recent weakness as a high-conviction way to gain exposure to Bitcoin. Maintain some cash to capitalize on short-term market volatility, as any significant dips are viewed as buying opportunities. The overall stock market is expected to perform well over a medium-term horizon of three-plus months. Long-term investors may also consider holding Bitcoin directly as a hedge against central bank policies. Finally, it is advised to avoid the real estate sector, as a meaningful recovery is not anticipated until around 2028.

Consider Tesla (TSLA) for its cluster of potential near-term catalysts in Q3, including a major Full Self-Driving (FSD) update and a potential sales surge before the US tax credit expires on September 30th. The recent sell-off in Hims & Hers Health (HIMS) is presented as a buying opportunity, as the market is incorrectly valuing it solely as a GLP-1 weight-loss company. HIMS is positioned as a long-term disruptive telehealth platform with major growth catalysts ahead in menopause treatments and international expansion. For a leveraged, long-term play on Bitcoin, look at MicroStrategy (MSTR), the analyst's largest holding. View any price weakness in MSTR as an opportunity to gain exposure to Bitcoin as a hedge against long-term fiat currency debasement.

Recent market fear has created a buying opportunity in MicroStrategy (MSTR), with the stock viewed as a deal around the $336 level due to its historically low premium over its Bitcoin holdings. Similarly, Bitcoin miner Marathon Digital (MARA) is considered undervalued as it trades near the value of its assets while actively accumulating more Bitcoin, a factor the market is ignoring. In telehealth, LifeMD (LFMD) is presented as a better deal than its peer Hims & Hers (HIMS), as it has lower lawsuit risk but has experienced a similar stock decline. LFMD is considered the more attractive opportunity until its stock price recovers towards the $10 level. The core strategy is to accumulate these high-conviction growth stocks during fear-driven sell-offs for long-term gains.

Major brokers have reclassified MicroStrategy (MSTR) as pristine collateral, lowering its margin maintenance requirement to just 25%. This upgrade places MSTR in the same top-tier category as Apple and the S&P 500, making it significantly easier and cheaper to borrow against. The development enhances MSTR's appeal as a premier vehicle for gaining leveraged exposure to Bitcoin within a standard brokerage account. The company is also resuming its share issuance program, a bullish signal of its commitment to its core mission of accumulating more Bitcoin. Investors comfortable with leverage can now use MSTR more effectively for strategies like securing loans or backing options plays with a lower risk of margin calls.

For investors bullish on Bitcoin, MicroStrategy (MSTR) is presented as a high-conviction, leveraged investment vehicle to amplify potential returns. With its valuation relative to its Bitcoin holdings near a one-year low, the current price may offer an attractive entry point for long-term believers. The investment thesis is entirely dependent on the long-term success of Bitcoin, with some models predicting a price of $1 million per coin by 2030-2031. Investors should monitor the success of its new preferred share product, Stretch, which is a key factor for funding future Bitcoin purchases. A potential Bitcoin bull run is anticipated to intensify this fall, which could serve as a significant near-term catalyst for both BTC and MSTR.

A significant decoupling has occurred between Bitcoin's stable price and its proxy stocks, presenting a compelling entry point for investors. MicroStrategy (MSTR) is highlighted as a top conviction idea, appearing undervalued after a 20% drop despite strong fundamentals and bullish guidance. For a valuation-driven play, consider CleanSpark (CLSK), which is described as very compelling at prices under $10. Marathon Digital (MARA) offers a unique value opportunity, trading at a discount to its Bitcoin holdings with the potential for a short squeeze due to high short interest. This market disconnect allows investors to acquire exposure to Bitcoin through these proxies at a significant discount.

KULR Technology Group (KULR) presents a high-conviction, long-term investment opportunity due to its specialized space technology and what is described as heavily negative market sentiment. The company, a key contractor for NASA, develops advanced thermal management for batteries and is guiding for 100% revenue growth in 2025. KULR is also executing a "stealth" Bitcoin (BTC) treasury strategy, using its shares to acquire the digital asset, which de-risks its growth-stage operations. The stock appears undervalued at 6.3 times enterprise-value-to-sales compared to peers like Amprius (AMPX) and SES AI (SES). Due to extreme volatility, investors should consider building a position in KULR common stock over time rather than using short-term options.

LifeMD (LFMD) presents a compelling investment opportunity as a significantly undervalued alternative to its larger competitor, Hims & Hers Health (HIMS). The analysis suggests LFMD is nearly three times cheaper than HIMS on a key valuation metric comparing enterprise value, gross profit, and revenue growth. LFMD is also viewed as a safer play, as it avoids the major lawsuit risk over compounded weight-loss drugs that currently overhangs HIMS. The company has multiple growth catalysts, including a newly launched mental health program and an upcoming women's health service. Furthermore, management has indicated that recent issues in its core RexMD erectile dysfunction business have been resolved, signaling a return to growth.

MicroStrategy (MSTR) has paused its key strategy of selling stock to acquire more Bitcoin, which was the primary driver of its past outperformance. This change could cause MSTR to underperform Bitcoin (BTC) in the short term, as the company is no longer actively increasing its holdings. The company will only resume this program if its stock premium reaches 2.5x its net asset value, a critical metric for investors to watch. While the long-term thesis on MSTR as a leveraged Bitcoin play remains, its mechanism for generating excess returns is currently inactive. As a cautionary tale, CleanSpark (CLSK) demonstrates that even a brilliant, value-accretive strategy can be punished by negative market sentiment.

CAVA Group (CAVA) presents a compelling long-term growth story similar to an early Chipotle (CMG), aiming to disrupt the Mediterranean food market. However, the stock is considered too expensive to buy at current levels due to its high valuation. A more attractive entry point for CAVA would be after a further price drop of 20% to 30%. The recent weakness is viewed as a broader fast-casual restaurant sector issue rather than a fundamental problem with the company. For investors seeking an alternative in the consumer space, Celsius Holdings (CELH) is highlighted as having a more attractive valuation.

For lower-volatility exposure to Bitcoin, consider MicroStrategy's preferred shares Strike (STRK), which offer a 7.3% yield and convertibility to MSTR common stock. The high-growth telehealth company Hims & Hers Health (HIMS) is viewed as an extremely compelling long-term investment. MicroStrategy (MSTR) itself is presented as a core "forever hold" to gain exposure to Bitcoin and as a hedge against currency devaluation. In the medical technology space, Delcath (DCTH) and CorMedix (CRMD) are highlighted as potentially better opportunities than Sanara MedTech (SMTI) due to higher growth. Despite recent weakness, Tesla (TSLA) is considered a core, high-quality holding that is expected to perform well over the long run.

MicroStrategy (MSTR) remains a core holding for leveraged Bitcoin exposure, as it continues to deliver returns of approximately 1.5x to 2x that of BTC. Although the company has temporarily paused its most effective method of funding Bitcoin purchases, a large acquisition is expected soon to meet stated targets. Investors should monitor MSTR's 8-K filings for announcements of new, significant Bitcoin buys. This aggressive acquisition strategy is based on a strong institutional belief that Bitcoin will generate a 29% annualized rate of return. This reinforces the long-term bullish case for holding BTC, but investors should remain prepared for characteristic short-term volatility.

The recent 20% price drop in AI beauty tech company Auditi (ODD) is viewed as an unwarranted buying opportunity for a profitable, fast-growing business. Similarly, telehealth company LifeMD (LFMD) is considered heavily undervalued after a 44% sell-off to around $6 per share. This drop is seen as a clear overreaction to temporary GLP-1 drug strategy issues, creating a compelling entry point. The market is ignoring LFMD's diversified and growing underlying business in mental health and other segments. For those bullish on the Buy Now, Pay Later theme, Sezzle (SEZL) is presented as the cheapest and fastest-growing option in the sector following its recent stock decline.

MicroStrategy (MSTR) is presented as a top investment idea, positioned for a potential short squeeze now that the company has paused issuing new shares. The stock is viewed as a leveraged play on Bitcoin that has historically outperformed, returning 31x over five years versus Bitcoin's 7x. This bullish thesis is supported by Bitcoin (BTC) recently surging past $119,000. For an alternative value play, consider MicroStrategy's preferred stocks, which are expected to rise if interest rates are cut in September. Specifically, the convertible preferred stock STRIKE is highlighted as an opportunity after its recent price drop to around $109.

Cormedix (CRMD) is presented as a strong buy, with its recent price drop viewed as a gift for investors before its acquisition of Melinta Therapeutics adds significant revenue. Oscar Health (OSCR) is another deeply undervalued turnaround play, with planned double-digit price increases expected to drive profitability next year. For long-term growth, consider Hims & Hers (HIMS) as it expands into massive new markets like hormone health and longevity. Patient investors may also find an opportunity in Delcath Systems (DCTH), which has fallen in price despite strong execution and holds significant long-term potential from its cancer treatment pipeline. These healthcare stocks are seen as undervalued due to market overreactions rather than poor company performance.

Consider buying The Real Brokerage (REAX), as its recent post-earnings stock drop is viewed as an irrational buying opportunity. This asset-light company is a long-term play on the eventual recovery of the real estate market, potentially by May 2026. In contrast, The Trade Desk (TTD) is a name to watch after its significant price drop, but it is not yet a buy at current levels. The business fundamentals for TTD remain strong, and it becomes an attractive purchase if the stock falls another 10-15%. Therefore, investors should consider setting a price alert for TTD while evaluating a position in REAX.